The popular diabetes drugs Actos and Avandia boost the risk of fracture in older women, according to findings from a new study that echo those of earlier research…
Read More »Diabetes In Control
Resveratrol May Reduce Inflammation, Help Diabetes
Resveratrol, the plant extract and potent anti-inflammatory previously shown to extend the survival of lower animal life, seems to reduce inflammation in humans as well. A reduction in blood vessel inflammation can help prevent development of diabetes, heart disease, stroke, and other health problems…
Read More »Texting Improves Treatment Adherence and Improved Glucose Levels
Pilot study supports adolescent diabetes patients through personalized text messages….
Read More »Aggressive Blood Sugar Control May Not Improve Survival in ESRD Patients
Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to a study…
Read More »FDA Accepts AFREZZA Resubmission and Sets Decision by Dec. 29, 2010
MannKind Corporation announced that it has submitted, and the U.S. Food and Drug Administration (FDA) has accepted, MannKind’s resubmission of its New Drug Application (NDA) for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set an action date …
Read More »New Information on CPR: Mouth to Mouth May Not Be Necessary
The results support a strategy for CPR performed by laypersons that emphasizes chest compression and minimizes the role of rescue breathing…
Read More »Decreasing Atherosclerosis Risk by Inhibiting Fatty Acids in Immune Cells
In this study, the research team inhibited atherosclerosis by interfering with production of a substance called fatty acid synthase…
Read More »Why Fad Diets Work Well for Some but Not Others
According to published research, genes are interacting with diet, rather than diet alone and are the main causes of variation in metabolic traits, such as body weight….
Read More »Letter from the Editor: “Our bags are packed and we’re ready to go”
Steve, Andrew and I are on our way to the 2010 AADE Annual Meeting & Exhibition in San Antonio, Texas. This should be a very interesting meeting because education is a major focus of the new national healthcare plan. The AADE has been at the forefront working with many different …
Read More »News Flash: FDA issues hold on Avandia vs Actos study…
FDA issues hold on Avandia vs Actos study: Federal health officials say new patients should not be enrolled in the study, after experts last week said Avandia increases heart risks. FDA Okays New Hypertension Polypill Tribenzor by Daiichi Sankyo: The pill contains a combination of three hypertension drugs — olmesartan …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.